Geistlich Biomaterials Launches The Alternative Soft-Tissue Graft
Geistlich Pharma North America, Inc. is excited to announce the addition of Geistlich Fibro-Gide® to its portfolio of collagen matrices. Made from Type I and Type III collagen, Geistlich Fibro-Gide® is smart-linked, a unique form of cross-linking, which provides elasticity, strength and volume stability. Positioned as the alternative connective tissue graft, Geistlich Fibro-Gide® is ideally suited for soft-tissue augmentation around natural teeth and implants. Additionally, Geistlich Fibro-Gide® is indicated for alveolar ridge reconstruction for prosthetic treatment and recession defects for root coverage.
"Geistlich Fibro-Gide® is one of the major innovations in regenerative dentistry in the last 20 years." proclaimed Dr. Daniel Thoma from Zurich, Switzerland.
In contrast to connective tissue grafts which are considered to be the "gold-standard" in soft-tissue augmentation and recession coverage procedures, Geistlich Fibro-Gide® does not require a second surgical site, is ready to use, and has an unlimited supply.
"Unlike connective tissue grafts, where you are limited by the patient's anatomy, Geistlich Fibro-Gide® offers variable thickness, allowing the clinician the opportunity to choose the desired and optimal thickness for the procedure." said Dr. Alan Fetner, Jacksonville, FL, USA.
Designing a preferred alternative to the soft-tissue graft has involved years of development and more than a thousand prototypes. Geistlich has drawn from its vast experience in researching, analysing and commercialising collagen based products tailor-made for specific dental procedures and therapeutic solutions. In both preclinical and clinical studies, Geistlich Fibro-Gide® demonstrates safety, efficacy and shows clinical comparability to a connective tissue graft. 1,2,3
Indications for Use:
Geistlich Fibro-Gide® is indicated for soft-tissue augmentation:
•Localized gingival augmentation to increase keratinized tissue around teeth and implants
•Alveolar ridge reconstruction for prosthetic treatment
•Recession defects for root coverage
1. Thoma DS. et al. J Clin Periodontol. 2016 Oct; 43(10): 874–85.
2. Thoma DS. et al. Clin Oral Implants Res. 2015 Mar; 26(3): 263–70.
3. Zeltner M. et al. J Clin Periodontol. 2017 Apr; 44(4): 446–453.
Source: Geistlich Pharma North America